APA

Mustacchi G., Puglisi F., Molino A. M., Crivellari D., Ghiotto C., Ferro A., Brunello A., Saracchini S., Turazza M., Cretella E., Iop A., Malagoli M. & Stefani M. (20160203). Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients. : Future oncology (London, England).

Chicago

Mustacchi G, Puglisi F, Molino A M, Crivellari D, Ghiotto C, Ferro A, Brunello A, Saracchini S, Turazza M, Cretella E, Iop A, Malagoli M and Stefani M. 20160203. Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients. : Future oncology (London, England).

Harvard

Mustacchi G., Puglisi F., Molino A. M., Crivellari D., Ghiotto C., Ferro A., Brunello A., Saracchini S., Turazza M., Cretella E., Iop A., Malagoli M. and Stefani M. (20160203). Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients. : Future oncology (London, England).

MLA

Mustacchi G, Puglisi F, Molino A M, Crivellari D, Ghiotto C, Ferro A, Brunello A, Saracchini S, Turazza M, Cretella E, Iop A, Malagoli M and Stefani M. Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients. : Future oncology (London, England). 20160203.